How did PACB's revenue and expenses shift in Q4 2024?
4/14/2025 03:15pm
Pacific Biosciences (PACB) experienced a total revenue of $39.22 million in Q4 2024, reflecting a significant increase from the previous quarter's revenue of $21.29 million, which indicates a strong financial performance in the period.
|code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code|
|---|---|---|---|---|---|---|
|PACB|PACB.O|Pacific Biosciences|2024 Q1|3.881E7||185|
|PACB|PACB.O|Pacific Biosciences|2024 Q2|3.6013E7||185|
|PACB|PACB.O|Pacific Biosciences|2024 Q3|3.9967E7||185|
|PACB|PACB.O|Pacific Biosciences|2024 Q4|3.9224E7||185|